Late-Stage Development, FDA Marketing Authorization, Procurement, and Stockpile of Antibiotics for the Treatment of Drug-Resistant Secondary Bacterial Infections And/Or the Treatment or PEP of Infections Caused by Biothreat Pathogens
Contract Overview
Contract Amount: $119,160,691 ($119.2M)
Contractor: Shionogi Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2026-04-06
End Date: 2036-03-10
Official Description: LATE-STAGE DEVELOPMENT, FDA MARKETING AUTHORIZATION, PROCUREMENT, AND STOCKPILE OF ANTIBIOTICS FOR THE TREATMENT OF DRUG-RESISTANT SECONDARY BACTERIAL INFECTIONS AND/OR THE TREATMENT OR PEP OF INFECTIONS CAUSED BY BIOTHREAT PATHOGENS.